The antinociceptive effects of magnesium sulfate and MK-801 in visceral inflammatory pain model: The role of NO/cGMP/K+ATP pathway

Pharmaceutical Biology

Volumn 53, Issue 11, 2015, Pages 1621-1627

  Vuckovic, Sonja ^a   Srebro, Dragana ^a   Vujovic, Katarina Savic ^a   Prostran, Milica ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Acetic acid induced writhing; Nitric oxide; NMDA antagonist; Rotarod

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYCLIC GMP; DIZOCILPINE; GLIBENCLAMIDE; MAGNESIUM SULFATE; METHYLENE BLUE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; ANALGESIC AGENT; DIZOCILPINE MALEATE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; INFLAMMATORY PAIN; MALE; NONHUMAN; RAT; ROTAROD TEST; VISCERAL INFLAMMATORY PAIN; VISCERAL PAIN; WRITHING TEST; ANIMAL; DRUG EFFECTS; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SUBCUTANEOUS DRUG ADMINISTRATION; WISTAR RAT;

ADENOSINE TRIPHOSPHATE; ANALGESICS; ANIMALS; CYCLIC GMP; DIZOCILPINE MALEATE; INJECTIONS, SUBCUTANEOUS; MAGNESIUM SULFATE; MALE; NITRIC OXIDE; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; VISCERAL PAIN;

EID: 84945955125     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2014.996821     Document Type: Article

References (53)

1. Alves D, Duarte I. (2002). Involvement of ATP-sensitive K(+) channels in the peripheral antinociceptive effect induced by dipyrone. Eur J Pharmacol 444:47-52
2. Andreasen JT, Bach A, Gynther M, et al. (2013). UCCB01-125, a dimeric inhibitor of PSD-95, reduces inflammatory pain without disrupting cognitive or motor performance: Comparison with the NMDA receptor antagonist MK-801. Neuropharmacology 67: 193-200
3. Assi AA. (2001). The influence of divalent cations on the analgesic effect of opioid and non-opioid drugs. Pharmacol Res 43:521-9
4. Begon S, Pickering G, Eschalier A, Dubray C. (2000). Magnesium and MK-801 have a similar effect in two experimental models of neuropathic pain. Brain Res 887:436-9
5. Begon S, Pickering G, Eschalier A, Dubray C. (2002). Magnesium increases morphine analgesic effect in different experimental models of pain. Anesthesiology 96:627-32
6. Bennett GJ. (2001). Animal models of pain. In: Kruger L, ed. Methods in Pain Research. Boca Raton: CRC Press, 67-91
7. Boyce S, Wyatt A, Webb JK, et al. (1999). Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: Correlation with restricted localisation of NR2B subunit in dorsal horn. Neuropharmacology 38:611-23
8. Bulutcu F, Dogrul A, GüçMO. (2002). The involvement of nitric oxide in the analgesic effects of ketamine. Life Sci 71:841-53
9. Chang JJ, Mack WJ, Saver JL, Sanossian N. (2014). Magnesium: Potential roles in neurovascular disease. Front Neurol 5:52(1-8)
10. Chi XX, Jiang X, Nicol GD. (2007). ATP-sensitive potassium currents reduce the PGE2-mediated enhancement of excitability in adult rat sensory neurons. Brain Res 1145:28-40
11. De Alba J, Clayton NM, Collins SD, et al. (2006). GW274150, a novel and highly selective inhibitor of the inducible isoform of nitric oxide synthase (iNOS), shows analgesic effects in rat models of inflammatory and neuropathic pain. Pain 120:170-81
12. Fawcett WJ, Haxby EJ, Male DA. (1999). Magnesium: Physiology and pharmacology. Br J Anaesth 83:302-20
13. Freire MA, Guimarães JS, Leal WG, Pereira A. (2009). Pain modulation by nitric oxide in the spinal cord. Front Neurosci 3:175-81
14. Galdino GS, Cortes SF, Duarte ID, Perez AC. (2010). Involvement of the nitric oxide/(C)GMP/K(ATP) pathway in antinociception induced by exercise in rats. Life Sci 86:505-9
15. Garrido-Suárez BB, Garrido G, Márquez L, et al. (2009). Pre-emptive anti-hyperalgesic effect of electroacupuncture in carrageenan-induced inflammation: Role of nitric oxide. Brain Res Bull 79:339-44
16. Granados-Soto V, Rufino MO, Gomes Lopes LD, Ferreira SH. (1997). Evidence for the involvement of the nitric oxide-cGMP pathway in the antinociception of morphine in the formalin test. Eur J Pharmacol 340:177-80
17. Hama A, Woon Lee J, Sagen J. (2003). Differential efficacy of intrathecal NMDA receptor antagonists on inflammatory mechanical and thermal hyperalgesia in rats. Eur J Pharmacol 459:49-58
18. Herroeder S, Schönherr ME, De Hert SG, Hollmann MW. (2011). Magnesium -Essentials for anesthesiologists. Anesthesiology 114: 971-93
19. Iseri LT, French JH. (1984). Magnesium: Nature's physiologic calcium blocker. Am Heart J 108:188-93
20. Jahangiri L, Kesmati M, Najafzadeh H. (2013). Evaluation of analgesic and anti-inflammatory effect of nanoparticles of magnesium oxide in mice with and without ketamine. Eur Rev Med Pharmacol Sci 17: 2706-10
21. Jesse CR, Savegnago L, Nogueira CW. (2007). Role of nitric oxide/ cyclicGMP/K(+) channel pathways in the antinociceptive effect caused by 2, 3 bis(mesitylseleno)propenol. Life Sci 81:1694-702
22. Kawabata A, Manabe S, Manabe Y, Takagi H. (1994). Effect of topical administration of L-arginine on formalin-induced nociception in the mouse: A dual role of peripherally formed NO in pain modulation. Br J Pharmacol 112:547-50
23. Kawamata T, Omote K. (1999). Activation of spinal N-methyl-Daspartate receptors stimulates a nitric oxide/cyclic guanosine 3, 5- monophosphate/glutamate release cascade in nociceptive signaling. Anesthesiology 91:1415-24
24. Koster R, Anderson M, De Beer EJ. (1958). Acetic acid for analgesic screening. Fed Proc 18:412-17
25. Lazaro-Ibanez GG, Torres-Lopez JE, Granados-Soto V. (2001). Participation of the nitric oxide-cyclic GMP-ATP-sensitive K(+) channel pathway in the antinociceptive action of ketorolac. Eur J Pharmacol 426:39-44
26. Li J, McRoberts JA, Nie J, et al. (2004). Electrophysiological characterization of N-methyl-D-aspartate receptors in rat dorsal root ganglia neurons. Pain 109:443-52
27. Liu HT, Hollmann MW, Liu WH, et al. (2001). Modulation of NMDA receptor function by ketamine and magnesium: Part I. Anesth Analg 92:1173-81
28. Milovanović M, Vučković S, Prostran M, et al. (2009). The effects of flunixin meglumine and L-name on the carrageenan-induced hyperalgesia in rats. (Proceedings Paper). 9th Congress of the European Association for Clinical Pharmacology and Therapeutics -EACPT 105:163-7
29. Mogil JS, Kest B, Sadowski B, Belknap JK. (1996). Differential genetic mediation of sensitivity to morphine in genetic models of opiate antinociception: Influence of nociceptive assay. J Pharmacol Exp Ther 276:532-44
30. Mohammad FK, Al-Baggou BKh, Naser AS. (2012). Antinociception by metoclopramide, ketamine and their combinations in mice. Pharmacol Rep 64:299-304
31. Muir KW, Lees KR. (1995). Clinical experience with excitatory amino acid antagonist drugs. Stroke 26:503-13
32. Nechifor M. (2011). Magnesium involvement in pain. Magnes Res 24: 220-2
33. Ortiz MI, Granados-Soto V, Castañeda-Hernández G. (2003). The NOcGMP- K+ channel pathway participates in the antinociceptive effect of diclofenac, but not of indomethacin. Pharmacol Biochem Behav 76: 187-95
34. Ortiz MI, Medina-Tato DA, Sarmiento-Heredia D, et al. (2006). Possible activation of the NO-cyclic GMP-protein kinase G-K+ channels pathway by gabapentin on the formalin test. Pharmacol Biochem Behav 83:420-7
35. Pathak D, Lopicic S, Stanojevic M, et al. (2009). Ethanol and magnesium suppress nickel-induced bursting activity in leech Retzius nerve cells. Gen Physiol Biophys 28:9-17
36. Romero TR, Duarte ID. (2013). Involvement of ATP-sensitive K(+) channels in the peripheral antinociceptive effect induced by ketamine. Vet Anaesth Analg 40:419-24
37. Rondón LJ, Privat AM, Daulhac L, et al. (2010). Magnesium attenuates chronic hypersensitivity and spinal cord NMDA receptor phosphorylation in a rat model of diabetic neuropathic pain. J Physiol 588: 4205-15
38. Sachs D, Cunha FQ, Ferreira SH. (2004). Peripheral analgesic blockade of hypernociception: Activation of arginine/NO/cGMP/protein kinase G/ATP-sensitive K+ channel pathway. Proc Natl Acad Sci USA 101: 3680-5
39. Sarantopoulos C, McCallum B, Sapunar D, et al. (2003). ATP-sensitive potassium channels in rat primary afferent neurons: The effect of neuropathic injury and gabapentin. Neurosci Lett 343:185-9
40. Shimosawa T, Takano K, Ando K, Fujita T. (2004). Magnesium inhibits norepinephrine release by blocking N-type calcium channels at peripheral sympathetic nerve endings. Hypertension 44:897-902
41. Srebro DP, Vučković S, Savić Vujović K, Prostran M. (2014). Antihyperalgesic effect of systemic magnesium sulfate in carrageenaninduced inflammatory pain in rats: Influence of nitric oxide pathway. Magnes Res 27:77-85
42. Strigo IA, Duncan GH, Bushnell MC, et al. (2005). The effects of racemic ketamine on painful stimulation of skin and viscera in human subjects. Pain 113:255-64
43. Suardíaz M, Estivill-Torrús G, Goicoechea C, et al. (2007). Analgesic properties of oleoylethanolamide (OEA) in visceral and inflammatory pain. Pain 133:99-110
44. Suetake-Koga S, Shimazaki T, Takamori K, et al. (2006). In vitro and antinociceptive profile of HON0001, an orally active NMDA receptor NR2B subunit antagonist. Pharmacol Biochem Behav 84:134-41
45. Takano Y, Sato E, Kaneko T, Sato I. (2000). Antihyperalgesic effects of intrathecally administered magnesium sulfate in rats. Pain 84:175-9
46. Tobin JR, Martin LD, Breslow MJ, Traystman RJ. (1994). Selective anesthetic inhibition of brain nitric oxide synthase. Anesthesiology 81: 1264-9
47. Vastani N, Seifert B, Spahn DR, Maurer K. (2013). Sensitivities of rat primary sensory afferent nerves to magnesium: Implications for differential nerve blocks. Eur J Anaesthesiol 30:21-8
48. Vučković SM, Tomić MA, Stepanović-Petrović RM, et al. (2006). The effects of alpha2-adrenoceptor agents on anti-hyperalgesic effects of carbamazepine and oxcarbazepine in a rat model of inflammatory pain. Pain 125:10-19
49. Willert RP, Woolf CJ, Hobson AR, et al. (2004). The development and maintenance of human visceral pain hypersensitivity is dependent on the N-methyl-D-aspartate receptor. Gastroenterology 126:683-92
50. Yamada K, Inagaki N. (2005). Neuroprotection by KATP channels. J Mol Cell Cardiol 38:945-9
51. Yonehara N, Amano K, Kamisaki Y. (2002). Involvement of the NMDA-nitric oxide pathway in the development of hypersensitivity to tactile stimulation in dental injured rats. Jpn J Pharmacol 90: 145-55
52. Yonehara N, Takemura M, Yoshimura M, et al. (1997). Nitric oxide in the rat spinal cord in Freund's adjuvant-induced hyperalgesia. Jpn J Pharmacol 75:327-35
53. Zhang XC, Zhang YQ, Zhao ZQ. (2006). Different roles of two nitric oxide activated pathways in spinal long-term potentiation of C-fiberevoked field potentials. Neuropharmacology 50:748-54